GlassScriptPhysician profile
Lauren Standridge
NPI 1487201059
$1,301.27
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $908 · 2022: $247 · 2024: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $173.23 | 2021-2022 | |
| Boston Scientific Corporation | $146.46 | 2024 | Watchman Flx |
| Abbott Laboratories | $141.15 | 2021 | |
| Xeris Pharmaceuticals, INC. | $109.29 | 2022 | |
| Abbvie INC. | $101.65 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $75.20 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.96 | 2021 | |
| Lilly USA, LLC | $73.95 | 2021 | |
| Amgen INC. | $63.18 | 2021 | |
| Novo Nordisk INC | $60.42 | 2021 | |
| Merck Sharp & Dohme LLC | $53.77 | 2021 | |
| Amarin Pharma, INC. | $42.15 | 2021 | |
| Endo Pharmaceuticals INC. | $41.71 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $39.00 | 2021 | |
| Radius Health, INC. | $25.49 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.59 | 2021 | |
| Vivus LLC | $22.22 | 2021 | |
| Antares Pharma, INC. | $21.35 | 2021 | |
| Clarus Therapeutics INC. | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Standridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.